Recent Announcements

FOR IMMEDIATE RELEASE

60K Physicians on Sermo Debate Medical News Before it Reaches the Mainstream Press

Physicians-Only Community Captures Early Insights from the Frontlines of Medicine

Cambridge, Mass., March 20, 2008 - Just this week, the U.S. Food and Drug Administration mandated that a warning be added to the prescribing information for the arthritis drug Enbrel to highlight the risk of potential infections, including tuberculosis. Although this topic just emerged in the mainstream media, physicians on Sermo have been discussing the risks to their patients since November of last year. While agreeing that the benefits far outweigh the risks, they debated whether nurses and healthcare practitioners taking Enbrel should refrain from direct patient contact to minimize any possibility of infection. Fortunately, the 60,000 physicians on Sermo do not have to wait for the FDA or the press to find out about important medical news.

Sermo is revolutionizing the way physicians collaborate nationwide. For physicians, Sermo has become an online meeting place to get opinions from thousands of colleagues about any issue related to their practice or patient care. It has also become a destination for organizations in the industry, such as the AMA and FDA, to listen to the collective voice of practicing physicians in real-time.

"At Sermo, we've established a platform that improves the way doctors practice medicine by bringing together observations and ideas in one place from thousands of physicians nationwide," said Dr. Adam Sharp, Chief Medical officer at Sermo. "The real-time dialogues taking place on Sermo are strong indicators of what issues the medical community is facing and what needs to happen to improve patient care."

In recent weeks some of the most hotly debated topics on Sermo have included:

• Are newer antidepressants ineffective in treating depression?
• Do You Prescribe Vitamin D after Parathyroidectomy?
• Will You Keep Using Proquad?
• Medicare Pay Cut - Why are We Accepting the Assignment?
• Will Google's EMR be Hack Proof?
• Intensive Lifestyle Counseling for Diabetes Reversal - Does it Work?
• Will Walmart Revolutionize Medicine with $4 Prescriptions?
• High BP: Is it Safe to Send Home - Or Go to ER?
• CTs in Toddlers - Consequences of Radiation Exposure?
• Do You Agree with the FDA Effort to Expand Effort of Off Label Prescribing?
• Lyrica as a Controlled Substance?

Press and analysts interested in learning more about these and other timely healthcare issues can contact Sermo at sermo@perkettpr.com.

About Sermo
Launched in September 2006, Sermo is already the largest online physician community in the US, with 60,000 physician members. On Sermo, physicians exchange knowledge with each other and gain potentially life saving insights directly from colleagues. Sermo harnesses the power of collective wisdom and enables physicians to discuss new clinical findings, report unusual events, and work together to improve patient care. Through its unique business model, Sermo is free to physicians and has no advertising or promotion. For more information about Sermo, visit www.sermo.com.

Press Contact:
Lisa Dilg
PerkettPR for Sermo
P:313-399-0892
E: sermo@perkettpr.com